Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H21NO2 |
| Molecular Weight | 247.3327 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)OC1(CCN(C)CC1)C2=CC=CC=C2
InChI
InChIKey=BCQMRZRAWHNSBF-UHFFFAOYSA-N
InChI=1S/C15H21NO2/c1-3-14(17)18-15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3
| Molecular Formula | C15H21NO2 |
| Molecular Weight | 247.3327 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Glucosylceramide synthesis inhibition affects cell cycle progression, membrane trafficking, and stage differentiation in Giardia lamblia. | 2010-09 |
|
| Modulation of amyloid precursor protein processing by synthetic ceramide analogues. | 2010-08 |
|
| Towards model-based control of Parkinson's disease. | 2010-05-13 |
|
| The mechanism of polyplex internalization into cells: testing the GM1/caveolin-1 lipid raft mediated endocytosis pathway. | 2010-02-01 |
|
| Apoptosis-induced inhibition of CD1d-mediated antigen presentation: different roles for caspases and signal transduction pathways. | 2008-09 |
|
| Involvement of gangliosides in glucosamine-induced proliferation decrease of retinal pericytes. | 2005-06 |
|
| Apoptosis of human carcinoma cells in the presence of potential anti-cancer drugs: III. Treatment of Colo-205 and SKBR3 cells with: cis -platin, Tamoxifen, Melphalan, Betulinic acid, L-PDMP, L-PPMP, and GD3 ganglioside. | 2004 |
|
| Apoptosis of human carcinoma cells in the presence of inhibitors of glycosphingolipid biosynthesis: I. Treatment of Colo-205 and SKBR3 cells with isomers of PDMP and PPMP. | 2004 |
|
| Designer drugs that are potent inhibitors of CYP2D6. | 2002-06 |
|
| Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. | 1979-12 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:59:01 GMT 2025
by
admin
on
Mon Mar 31 18:59:01 GMT 2025
|
| Record UNII |
07SGC963IR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
9661
Created by
admin on Mon Mar 31 18:59:01 GMT 2025 , Edited by admin on Mon Mar 31 18:59:01 GMT 2025
|
||
|
WIKIPEDIA |
Designer-drugs-Desmethylprodine
Created by
admin on Mon Mar 31 18:59:01 GMT 2025 , Edited by admin on Mon Mar 31 18:59:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
13147-09-6
Created by
admin on Mon Mar 31 18:59:01 GMT 2025 , Edited by admin on Mon Mar 31 18:59:01 GMT 2025
|
PRIMARY | |||
|
DESMETHYLPRODINE
Created by
admin on Mon Mar 31 18:59:01 GMT 2025 , Edited by admin on Mon Mar 31 18:59:01 GMT 2025
|
PRIMARY | |||
|
61583
Created by
admin on Mon Mar 31 18:59:01 GMT 2025 , Edited by admin on Mon Mar 31 18:59:01 GMT 2025
|
PRIMARY | |||
|
DTXSID80157061
Created by
admin on Mon Mar 31 18:59:01 GMT 2025 , Edited by admin on Mon Mar 31 18:59:01 GMT 2025
|
PRIMARY | |||
|
07SGC963IR
Created by
admin on Mon Mar 31 18:59:01 GMT 2025 , Edited by admin on Mon Mar 31 18:59:01 GMT 2025
|
PRIMARY | |||
|
DB01478
Created by
admin on Mon Mar 31 18:59:01 GMT 2025 , Edited by admin on Mon Mar 31 18:59:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |